Sage Publications Ltd.

SHERPA: Unknown

People

  1. Jhaveri
    Jhaveri
  2. Bajorin
    Bajorin
  3. Dang
    Dang
  4. Goldfarb
    Goldfarb
  5. Hudis
    Hudis
  6. Ilson
    Ilson
  7. Iyer
    Iyer
  8. Modi
    Modi
  9. Razavi
    Razavi
  10. Saltz
    Saltz

Groups

  1. Department of Medicine (13)
  2. Solid Tumor Oncology Division (13)
  3. Breast Medicine Service (6)
  4. Genitourinary Oncology Service (5)
  5. Gastrointestinal Oncology Service (2)
  6. Survivorship Research (2)
  7. Epidemiology and Biostatistics (1)
  8. Health Outcomes Research Group (1)
  9. Population Sciences Research Program (1)
  10. Weinberg Fellows (1)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (7)
  2. Review (6)
Groups
  1. Department of Medicine (13)
  2. Solid Tumor Oncology Division (13)
  3. Breast Medicine Service (6)
  4. Genitourinary Oncology Service (5)
  5. Gastrointestinal Oncology Service (2)
  6. Survivorship Research (2)

More Groups

People
  1. Komal Jhaveri (2)
  2. Arjun Balar (1)
  3. Chau Dang (1)
  4. Chung-Han Lee (1)
  5. Clifford Hudis (1)
  6. David Ilson (1)

More People

Years
  1. 2023 (4)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2011 (2)

More Years

Publications
  1. Therapeutic Advances in Medical Oncology (10)
  2. Therapeutic Advances in Urology (2)
  3. Journal of Circulating Biomarkers (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting HER2-low in metastatic breast cancer: An evolving treatment paradigm
    Review

    Yang, C.; Brezden-Masley, C.; Joy, A. A.; Sehdev, S.; Modi, S.; Simmons, C.; Henning, J. W.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: A matching-adjusted indirect comparison
    Journal Article

    Rugo, H. S.; Harmer, V.; O’Shaughnessy, J.; Jhaveri, K.; Tolaney, S. M.; Cardoso, F.; Bardia, A.; Maheshwari, V. K.; Tripathi, S.; Haftchenary, S.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: Current and emerging role
    Review

    Lloyd, M. R.; Wander, S. A.; Hamilton, E.; Razavi, P.; Bardia, A.
    Therapeutic Advances in Medical Oncology (2022)

    Fulltext@MSK | Save
  • Novel emerging biomarkers to immunotherapy in kidney cancer
    Review

    Ged, Y.; Voss, M. H.
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • New approaches to first-line treatment of advanced renal cell carcinoma
    Review

    George, D. J.; Lee, C. H.; Heng, D.
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: An ARCAD database analysis
    Journal Article

    Yin, J.; Dawood, S.; Cohen, R.; Meyers, J.; Zalcberg, J.; Yoshino, T.; Seymour, M.; Maughan, T.; Saltz, L.; Van Cutsem, E.; more...
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer
    Journal Article

    Lu, D.; Krupa, R.; Harvey, M.; Graf, R. P.; Schreiber, N.; Barnett, E.; Carbone, E.; Jendrisak, A.; Gill, A.; Orr, S.; more...
    Journal of Circulating Biomarkers (2020)

    Fulltext@MSK | Save
  • Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: Clinical trial evidence and experience
    Review

    Crist, M.; Iyer, G.; Hsu, M.; Huang, W. C.; Balar, A. V.
    Therapeutic Advances in Urology (2019)

    Fulltext@MSK | Save

    • Sage Publications Ltd. – authorized name for: